Genomic and proteomic contributions for chagas disease control;Contribuciones de la genética y la proteómica al estudio de la enfermedad de Chagas

Salud Publica de Mexico

Volumn 51, Issue SUPPL.3, 2009, Pages

  López Ordoñez acute, Teresa ^a   Panzera, Francisco ^b,c   Ezequiel Tun Ku, Biól ^a   Ferrandis, Inés ^c   Ramsey, Janine M ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^c UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

Author keywords

Chagas disease; Triatominae; Trypanosoma cruzi

Indexed keywords

ANIMAL; CHAGAS DISEASE; DISEASE CARRIER; DISEASE TRANSMISSION; GENETICS; GENOMICS; HUMAN; PROTEOMICS; REVIEW; TRIATOMA; TRYPANOSOMA CRUZI;

ANIMALS; CHAGAS DISEASE; DISEASE VECTORS; GENOMICS; HUMANS; PROTEOMICS; TRIATOMA; TRYPANOSOMA CRUZI;

EID: 77956986021     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: 10.1590/S0036-36342009000900007     Document Type: Article

References (157)

1. World Health Organization. Control of Chagas disease. WHO Technical Report Series 811. Ginebra: WHO, 1991.
2. World Bank. World Development Report 1993. Investing in Health. New York: Oxford University Press, 1993.
3. Morel CM, Lazdins J. Chagas disease. Nat Rev Microbiol 2003;1:14-15.
4. Dias JC, Silveira AC. Chagas disease in the Americas: current situation and perspectives. Rev Soc Bras Med Trop 2005;38(Suppl 2:5-13).
5. Schofield CJ, Jannin J, Salvatella R. The future of Chagas disease Control. Trends Parasitol 2006;22:583-588.
6. Ramsey JM, Tello-López A, Pohls JL. Iniciativa para la vigilancia y control de la enfermedad de Chagas en la República Mexicana. México: Instituto Nacional de Salud Pública, 2003.
7. El-Sayed NM, Myler PJ, Bartholomeu DC, Nilsson D, Aggarwal G, Tran AN, et al. The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science 2005;309:409-415.
8. Schofield CJ, Dias JCP. The Southern Cone Initiative against Chagas disease. Adv Parasitol 1999;42:1-27.
9. Monteiro FA, Escalante AA, Beard CB. Molecular tools and triatomine systematics: a public health perspective. Trends Parasitol 2001;17:344-347.
10. Mota J, Chacon JC, Gutierrez-Cabrera AE, Sanchez-Cordero V, Wirtz RA, Ordoñez R, et al. Identification of blood meal source and infection with Trypanosoma cruzi of Chagas disease vectors using a multiplex cytochrome b polymerase chain reaction assay. Vector Borne Zoonotic Dis 2007;7(4):617-627.
11. Lent H, Wygodzinsky P. Revision of the Triatominae (Hemiptera, Reduviidae), and their significance as vectors of Chagas disease. Bull Am Mus Nat His 1979;163:123-520.
12. Dujardin J, Panzera P, Schofield CJ. Triatominae as a model of morphological plasticity under ecological pressure. Mem Inst Oswaldo Cruz 1999;94:223-228.
13. Pereira J, Dujardin JP, Salvatella R, Tibayrenc M. Enzymatic variability and phylogenetic relatedness among Triatoma infestans, T. platensis, T. delpontei and T. rubrovaria. Heredity 1996;77:47-54.
14. Panzera F, Hornos S, Pereira J, Cestau R, Canale D, Diotaiuti L, et al. Genetic variability and geographic differentiation among three species of triatomine bugs (Hemiptera-Reduvidae). Am J Trop Med Hyg 1997;57:732-739.
15. Noireau F, Gutierrez T, Zegarra M, Flores R, Breniere SF, Cardozo L, et al. Cryptic speciation in Triatoma sordida (Hemiptera: Reduviidae) from the Bolivian Chaco. Trop Med Int Health 1998;3:364-372.
16. Monteiro FA, Donnelly MJ, Beard CB, Costa J. Nested clade and phylogeographic analyses of the Chagas disease vector Triatoma brasiliensis in Northeast Brazil. Mol Phyl Evol 2004;32:46-56.
17. Marcilla A, Bargues MD, Ramsey JM, Magallon-Gastelum E, Salazar-Schettino PM, Abad-Franch F, et al. The ITS-2 of the nuclear rDNA as a molecular marker for populations, species, and phylogenetic relationships in Triatominae (Hemiptera: Reduviidae), vectors of Chagas disease. Mol Phyl Evol 2001;18:136-142.
18. Panzera F, Ferrandis I, Ramsey J, Ordoñez R, Salazar-Schettino PM, Cabrera M, et al. Chromosomal variation and genome size support existence of cryptic species of Triatoma dimidiata with different epidemiological importance as Chagas Disease vectors. Trop Med Int Health 2006;11:1092-1103.
19. Catala S, Sachetto C, Moreno M, Rosales R, Salazar-Schetrino PM, Gorla D. Antennal phenotype of Triatoma dimidiata populations and its relationship with species of phyllosoma and protracta complexes. J Med Entomol 2005;42(5):719-725.
20. Dujardin JP, Schofield CJ, Panzera F. Los vectores de la enfermedad de Chagas. Bruselas: Académie Royale des Sciences d'Outre-Mer, 2002.
21. Abad-Franch F, Monteiro FA. Molecular research and the control of Chagas disease vectors. An Acad Bras Cienc 2005;77(3):437-454.
22. Torrico RA. Hallazgo de Eratyrus mucronatus, infestación natural de "vinchucas" de cerro y Eutriatoma sordida en Cochabamba. Ann Lab Central Cochabamba 1946;1:19-23.
23. Dujardin JP, Tibayrenc M, Venegas E, Maldonado L, Desjeux P, Ayala F. Isozyme evidence of lack of speciation between wild an domestic Triatoma infestans (Heteroptera: Reduviidae) in Bolivia. J Med Entomol 1987;24:40-45.
24. Bermudez H, Valderrama F, Torrico F. Identification and characterization of sylvatic foci of Triatoma infestans in Central Bolivia. Am J Trop Med Hyg 1993;49:371.
25. Schofield CJ. The biosystematics of Triatominae. In: Service MW, comp. Biosystematics of Haematophagous Insects. Oxford: Clarendon Press, 1988:284-312.
26. Dujardin JP, Schofield CJ, Tibayrenc M. Population structure of Andean Triatoma infestans: allozyme frequencies and their epidemiological relevance. Med Vet Entomol 1998;12:20-29
27. Panzera F, Dujardin JP, Nicolini P, Caraccio MN, Rose V, Tellez T, et al Genomic changes of Chagas disease vector, South America. Emerg Infect Dis 2004;10:438-436.
28. Martinez A, Olmedo RA, Carcavallo RU. Una nueva subespecie argentina de Triatoma infestans. Chagas 1987;4:479-480.
29. Noireau F, Bastrenta B, Catala S, Dujardin JP, Panzera F, Torres M, et al. Silvatic population of Triatoma infestans from the Bolivian Chaco: from field collection to characterization. Mem Inst Oswaldo Cruz 2000;95:119-122.
30. Schofield CJ, Diotaiuti L, Dujardin JP. The process of domestication in Triatominae. Mem Inst Oswaldo Cruz 1999;94:375-378.
31. Dujardin JP, Bermudez H, Schofield CJ. The use of morphometrics in entomological surveillance of sylvatic foci of Triatoma infestans in Bolivia. Acta Tropica 1997;66:145-153.
32. Noireau F, Rojas-Cortez MG, Monteiro FA, Jansen AM, Torrico F. Can wild Triatoma infestans foci in Bolivia jeopardize Chagas disease control efforts ?. Trends Parasitol 2005;21:7-10.
33. Garcia BA, Zheng LO, Pérez-de Rosas AR, Segura EL. Primer note. Isolation and characterization of polymorphic microsatellite loci in the Chagas' disease vector Triatoma infestans (Hemiptera: Reduviidae). Mol Ecol Notes 2004;4:568-571.
34. Marcet PL, Lehmann T, Groner G, Gurtler RE, Kitron U, Dotson EM. Identification and characterization of microsatellite markers in the Chagas disease vector Triatoma infestans (Heteroptera: Reduviidae). Infec Genet Evol 2006;6:32-37.
35. Picollo MI, Vassena C, Santo-Orihuela P, Barrios S, Zaidemberg M, Zerba E. High resistance to pyrethroid insecticides associated with ineffective field treatments in Triatoma infestans (Hemiptera: Reduviidae) from Northern Argentina. J Med Entomol 2005;42:637-642.
36. Toloza AC, Germano M, Cueto GM, Vassena C, Zerba E, Picollo MI. Differential patterns of insecticide resistance in eggs and first instars of Triatoma infestans (Hemiptera: Reduviidae) from Argentina and Bolivia. J Med Entomol 2008;45:421-426.
37. Orihuela PL, Vassena CV, Zerba EN, Picollo MI. Relative contribution of monooxygenase and esterase to pirethroid resistance in Triatoma infestans (Hemiptera: Reduviidae) from Argentina and Bolivia. J Med Entomol 2008;45:298-306.
38. Zeledón R. Some historical facts and recent issues related to the presence of Rhodnius prolixus (Stal, 1859) (Hemiptera, Reduviidae) in Central America. Entomol Vect 2004;11:233-246.
39. Dujardin JP, Muñoz M, Chavez T, Ponce C, Moreno J, Schofield CJ. The origin of Rhodnius prolixus in Central America. Med Vet Entomol 1998;12:113-115.
40. Yamagata Y, Nakagawa J. Control of Chagas disease. Adv Parasitol 2006;61:129-165.
41. Villegas J, Feliciangeli MD, Dujardin JP. Wing shape divergence between Rhodnius prolixus from Cojedes (Venezuela) and Rhodnius robustus from Mérida (Venezuela). Infec Genet Evol 2002;2:121-128.
42. Feliciangeli MD, Dujardin JP, Bastrenta B, Mazzarri M, Villegas J, Flores M, et al. Is Rhodnius robustus (Hemiptera: Reduviidae) responsible for Chagas disease transmission in Western Venezuela? Trop Med Int Health 2002;7:280-287.
43. Monteiro FA, Barrett TV, Fitzpatrick S, Cordon-Rosales C, Feliciangeli D, Beard CB. Molecular phylogeography of the Amazonian Chagas disease vectors Rhodnius prolixus and R. robustus. Mol Ecol 2003;12:997-1006.
44. Panzera F, Ferrandis I, Ramsey J, Salazar-Schettino PM, Cabrera M, Monroy C, et al. Genome size determination in Chagas Disease transmitting bugs (Hemiptera -Triatominae) by flow cytometry. Am J Trop Med Hyg 2007;76(3):516-521.
45. Dorn PL, Monroy C, Curtis A. Triatoma dimidiata (Latreille, 1811): a review of its diversity across its geographic range and the relationship among populations. Infect Genet Evol 2007;7(2):343-352.
46. Zeledón R. El Triatoma dimidiata (Latreille 1811) y su relación con la enfermedad de Chagas. San José, Costa Rica: INCIENSA/EUNED, 1981.
47. Ponce C. Elimination of the vectorial transmission of Chagas disease in Central American countries: Honduras. Mem Inst Oswaldo Cruz 1999;94(Suppl 1):417-418.
48. Abad-Franch F, Paucar CA, Carpio CC, Cuba-Cuba CA, Aguilar VHM, Miles MA. Biogeography of Triatominae in Ecuador: implications for the design of control strategies. Mem Inst Oswaldo Cruz 2001;96:611-620.
49. Harris, K. Taxonomy and Phylogeny of North American Triatominae: Public Health Implications. (Tesis). Atlanta (GA): Moorehouse School of Medicine, 2003.
50. Calderon-Fernandez G, Juarez MP, Ramsey J, Salazar-Schettino PM, Monroy MC, Ordonez R, et al. Cuticular hydrocarbon variability among Triatoma dimidiata (Hemiptera:Reduviidae) populations from Mexico and Guatemala. J Med Entomol 2005;42:780-788.
51. Lehmann P, Ordonez R, Ojeda-Baranda R, de Lira JM, Hidalgo-Sosa L, Monroy C, et al. Morphometric analysis of Triatoma dimidiata populations (Reduviidae:Triatominae) from Mexico and Northern Guatemala. Mem Inst Oswaldo Cruz 2005;100:477-482.
52. Bargues MD, Klisiowicz DR, Gonzalez-Candelas F, Ramsey JM, Monroy C, Ponce C, et al. Phylogeography and genetic variation of Triatoma dimidiata, the main Chagas disease vector in Central America, and its position within the genus Triatoma. PLoS Negl Trop Dis 2008;2(5):e233.
53. Schofield CJ. Evolución y control del Triatoma dimidiata. En: Taller para el establecimiento de pautas técnicas en el control de Triatoma dimidiata, San Salvador, Documento PAHO OPS/HCP/HCT/214/02, 2002:12-18.
54. Schofield CJ. Propuestas de estrategias para el control de Triatoma dimidiata en Colombia. En: Primer Taller Internacional sobre Control de la Enfermedad de Chagas (F Guhl, ed.). Bogotá: Universidad de Los Andes, 2005:55-61.
55. Flores A, Magallon-Gastelum E, Bosseno MF, Ordoñez R, Lozano-Kasten F, Espinoza B, et al. Isoenzyme variability of five principal triatomine vector species of Chagas disease in Mexico. Infec Genet Evol 2001;1:21-28.
56. Martinez F, Alejandre-Aguilar R, Moncada YH, Espinoza B. Molecular taxonomic study of Chagas disease vectors from the phyllosoma, lecticularia, and rubrofasciata complexes. Am J Trop Med Hyg 2005;73:321-325.
57. Breniere SF, Taveira B, Bosseno MF, Ordoñez R, Lozano-Kasten F, Magallón-Gastélum E, et al. Preliminary results of random amplification of polymorphic DNA among triatominae of the phyllosoma complex (H, R). Mem Inst Oswaldo Cruz 2003;98:1033-1038.
58. Martinez FH, Villalobos GC, Cevallos AM, Torre P de L, Laclette JP, Alejandre-Aguilar R, et al. Taxonomic study of the Phyllosoma complex and other triatomine (Insecta: Hemiptera: Reduviidae) species of epidemiological importance in the transmission of Chagas disease: using ITS-2 and mtCytB sequences. Mol Phyl Evol 2006;41(2):279-287.
59. Pfeiler E, Bitler BG, Ramsey JM, Palacios-Cardiel C, Markow TA. Genetic variation, population structure, and phylogenetic relationships of Triatoma rubida and T. recurva (H:R:T) from the Sonoran Desert, insect vectors of the Chagas' disease parasite Trypanosoma cruzi. Mol Phyl Evol 2006;41:209-211.
60. WHO. Control of Chagas Disease: Second Report of the WHO Expert Committee. World Health Organ Tech Rep Ser 2002;905:1-109.
61. Abad-Franch F, Monteiro FA, Aguilar VHM, Miles MA. Population-level mitochondrial DNA sequence diversity in Rhodnius ecuadoriensis. Abs. IX European Multicolloquium of Parasitology; 2004; Valencia, Spain.
62. Barbosa SE, Diotaiuti L, Soares RPP, Pereira MH. Differences in saliva composition among three Brazilian populations of Panstrongylus megistus (Hemiptera, Reduviidae). Acta Tropica 1999;72:91-98.
63. Diotaiuti L, Faria Filho OF, Carneiro FC, Dias JC, Pires HH, Schofield CJ. Operational aspects of Triatoma brasiliensis control. Cad Saude Publica 2000;16(Suppl 2):61-67.
64. Ramsey JM, Cruz-Celis A, Salgado L, Espinosa L, Ordonez R, Lopez R, et al. Efficacy of pyrethroid insecticides against domestic and peridomestic populations of Triatoma pallidipennis and Triatoma barberi (Reduviidae:Triatominae) vectors of Chagas' disease in Mexico. J Med Entomol 2003;40:912-920.
65. Ramirez CJ, Jaramillo CA, Delgado MP, Pinto NA, Aguilera G, Guhl F. Genetic structure of sylvatic, peridomestic and domestic populations of Triatoma dimidiata (Hemiptera: Reduviidae) from an endemic zone of Boyaca, Colombia. Acta Tropica 2005;93:23-29.
66. Ramsey JM, Alvear AL, Ordonez R, Munoz G, Garcia A, Lopez R, et al. Risk factors associated with house infestation by the Chagas disease vector Triatoma pallidipennis in Cuernavaca metropolitan area, Mexico. Med Vet Entomol 2005;19:219-228.
67. Borges EC, Dujardin JP, Schofield CJ, Romanha AJ, Diotaiuti L. Dynamics between sylvatic, peridomestic and domestic populations of Triatoma brasiliensis (Hemiptera: Reduviidae) in Ceará State, Northeastern Brazil. Acta Tropica 2005;93:119-126.
68. OPS-MSF. Curso de capacitación médica en el diagnóstico, manejo y tratamiento de la enfermedad de Chagas. Washington, DC: OPS, 2004.
69. Avila HA, Sigman DS, Cohen LM, Millikan RC, Simpson L. Polymerase chain reaction amplification of Trypanosoma cruzi kinetoplast minicircle DNA isolated from whole blood lysates: Diagnosis of chronic Chagas disease. Mol Biochem Parasitol 1991;48:211-222.
70. Russomando A, Figueredo A, Almiron M, Sakamoto M, Morita K. Polymerase chain reaction-based detection of Trypanosoma cruzi DNA in serum. J Clin Microbiol 1992;30:2864-2868.
71. Marcon GE, Andrade PD, de Albuquerque DM, Wanderley da S, de Almeida EA, Guariento ME, et al. Use of a nested polymerase chain reaction (N-PCR) to detect Trypanosoma cruzi in blood samples from chronic chagasic patients and patients with doubtful serologies. Diagn Microbiol Infect Dis 2002;43:39-43.
72. Van Voorhis WC, Barrett L, Koelling R, Farr AG. FL-160 proteins of Trypanosoma cruzi are expressed from a multigene family and contain two distinct epitopes that mimic nervous tissues. J Exp Med 1993;178:681-694.
73. Lane JE, Olivares-Villagomez D, Vnencak-Jones CL, McCurley TL, Carter CE. Detection of Trypanosoma cruzi with the polymerase chain reaction and in situ hybridization in infected murine cardiac tissue. Am J Trop Med Hyg 1997;56:588-595.
74. Lane JE, Ribeiro-Rodrigues R, Olivares-Villagomez D, Vnencak-Jones CL, McCurley TL, Carter CE. Detection of Trypanosoma cruzi DNA within murine cardiac tissue sections by in situ polymerase chain reaction. Mem Inst Oswaldo Cruz 2003;98:373-376.
75. Avila HA, Pereira JB, Thiemann O, De Paiva E, DeGrave W, Morel CM, et al. Detection of Trypanosoma cruzi in blood specimens of chronic chagasic patients by polymerase chain reaction amplification of kinetoplast minicircle DNA: comparison with serology and xenodiagnosis. J Clin Microbiol 1993;31:2421-2426.
76. Gomes ML, Galvao LM, Macedo AM, Pena SD, Chiari E. Chagas' disease diagnosis: comparative analysis of parasitologic, molecular, and serologic methods. Am J Trop Med Hyg 1999;60:205-210.
77. Vallejo GA, Guhl F, Chiari E, Macedo AM. Species specific detection of Trypanosoma cruzi and Trypanosoma rangeli in vector and mammalian hosts by polymerase chain reaction amplification of kinetoplast minicircle DNA. Acta Tropica 1999;72:203-212.
78. Miyamoto CT, Gomes ML, Marangon AV, Araujo SM, Bahia MT, Lana M, et al. Trypanosoma cruzi: sensitivity of the polymerase chain reaction for detecting the parasite in the blood of mice infected with different clonal genotypes. Exp Parasitol 2006;112:198-201.
79. Dorn PL, Engelke D, Rodas A, Rosales R, Melgar S, Brahney B, et al. Utility of the polymerase chain reaction in detection of Trypanosoma cruzi in Guatemalan Chagas' disease vectors. Am J Trop Med Hyg 1999;60:740-745.
80. Centurion-Lara A, Barrett L, Van Voorhis WC. Quantitation of parasitemia by competitive polymerase chain reaction amplification of parasite kDNA minicircles during chronic infection with Trypanosoma cruzi. J Infect Dis 1994;170:1334-1339.
81. Carvalho MR, Krieger MA, Almeida E, Oelemann W, Shikanai-Yassuda MA, Ferreira AW, et al. Chagas' disease diagnosis: evaluation of several tests in blood bank screening. Transfusion 1993;33:830-834.
82. Umezawa ES, Silveira JF. Serological diagnosis of Chagas disease with purified and defined Trypanosoma cruzi antigens. Mem Inst Oswaldo Cruz 1999;94(Suppl 1):285-288.
83. Monteon VM, Guzman-Rojas L, Negrete-Garcia C, Rosales-Encina JL, Lopez PA. Serodiagnosis of American trypanosomiasis by using nonpathogenic trypanosomatid antigen. J Clin Microbiol 1997;35:3316-3319.
84. Perez-Fuentes R, Sanchez-Guillen MC, Gonzalez-Alvarez C, Monteon VM, Reyes PA, Rosales-Encina JL. Humoral nitric oxide levels and antibody immune response of symptomatic and indeterminate Chagas' disease patients to commercial and autochthonous Trypanosoma cruzi antigen. Am J Trop Med Hyg 1998;58:715-720.
85. Umezawa ES, Luquetti AO, Levitus G, Ponce C, Ponce E, Henriquez D, et al. Serodiagnosis of chronic and acute Chagas' disease with Trypanosoma cruzi recombinant proteins: results of a collaborative study in six Latin American countries. J Clin Microbiol 2004;42:449-452.
86. Gadelha AA, Vercosa AF, Lorena VM, Nakazawa M, Carvalho AB, Souza WV, et al. Chagas' disease diagnosis: comparative analysis of recombinant ELISA with conventional ELISA and the haemagglutination test. Vox Sang 2003;85:165-170.
87. Ramos-Ligonio A, Lopez-Monteon A, Talamas-Rohana P, Rosales-Encina JL. Recombinant SSP4 protein from Trypanosoma cruzi amastigotes regulates nitric oxide production by macrophages. Parasite Immunol 2004;26:409-418.
88. Chang CD, Cheng KY, Jiang LX, Salbilla VA, Haller AS, Yem AW, et al. Evaluation of a prototype Trypanosoma cruzi antibody assay with recombinant antigens on a fully automated chemiluminescence analyzer for blood donor screening. Transfusion 2006;46(10):1737-1744.
89. Cheng KY, Chang CD, Salbilla VA, KirchhoffLV, Leiby DA, Schochetman G, et al. Immunoblot assay using recombinant antigens as a supplemental test to confirm the presence of antibodies to Trypanosoma cruzi. Clin Vaccine Immunol 2007;14(4):355-361.
90. Doménech-Sánchez A, Vila J. Fundamentos, tipos y aplicaciones de los arrays de ADN en la microbiología médica. Enferm Infecc Microbiol Clin 2004;22(1):46-54.
91. Guo Y, Fu Z, Van Eyk JE. A proteomic primer for the clinician. Proc Am Thorac Soc 2007;4(1):9-17.
92. Sartain MJ, Slayden RA, Singh KK, Laal S, Belisle JT. Disease state differentiation and identification of tuberculosis biomarkers via native antigen array profiling. Mol Cell Proteomics 2006;5(11):2102-2113.
93. Palacios G, Quan PL, Jabado OJ, Conlan S, Hirschberg DL, Liu Y, et al. Panmicrobial oligonucleotide array for diagnosis of infectious diseases. Emerg Infect Dis 2007;13(1):73-81.
94. Rodríguez-Morales AJ. Nuevas perspectivas en el manejo terapéutico de la enfermedad de Chagas. Rev Peru Med Exp Salud Publica 2005;22:123-133.
95. OPS/MSF Regional Consultation Technique on Organization and Structure of the Medical Attention of patient with Chagas disease. Rev Soc Bras Med Trop 2005;38:538-541.
96. Caffrey CR, Scory S, Steverding D. Cysteine proteinases of trypanosome parasites: novel targets for chemotherapy. Curr Drug Targets 2000;1:155-162
97. Cazzulo J, Stoka V, Turk V The major cysteine proteinase of Trypanosoma cruzi: a valid target for chemotherapy of Chagas disease. Curr Pharm Des 2001;7:1143-1156.
98. Urbina JA. Chemotherapy of Chagas' disease: the how and the why. J Mol Med 1999;77:332-338.
99. Urbina JA, Payares G, Sanoja C, Molina J, Lira R, Brener Z, et al. Parasitological cure of acute and chronic experimental Chagas disease using the long-acting experimental triazole TAK-187. Activity against drug-resistant Trypanosoma cruzi strains. Int J Antimicrob Agents 2003;21:39-48.
100. Urbina JA, Concepcion JL, Montalvetti A, Rodriguez JB, Docampo R. Mechanism of action of 4-phenoxyphenoxyethyl thiocyanate (WC-9) against Trypanosoma cruzi, the causative agent of Chagas' disease. Antimicrob Agents Chemother 2003;47:2047-2050.
101. Tasdemir D, Kaiser M, Brun R, Yardley V, Schmidt TJ, Tosun F, et al. Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: in vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies. Antimicrob Agents Chemother 2006;50:1352-1364.
102. Silber AM, Colli W, Ulrich H, Alves MJ, Pereira CA. Amino acid metabolic routes in Trypanosoma cruzi: possible therapeutic targets against Chagas' disease. Curr Drug Targets Infect Disord 2005;5:53-64.
103. Senkovich O, Bhatia V, Garg N, Chattopadhyay D. Lipophilic antifolate trimetrexate is a potent inhibitor of Trypanosoma cruzi: prospect for chemotherapy of Chagas' disease. Antimicrob Agents Chemother 2005;49:3234-3238.
104. Agusti R, Paris G, Ratier L, Frasch AC, de Lederkremer RM. Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo. Glycobiology 2004;14:659-670.
105. Cooper RA, Carucci DJ. Proteomic approaches to studying drug targets and resistance in Plasmodium. Curr Drug Targets Infect Disord 2004;4(1):41-51.
106. Sodré CL, Chapeaurouge AD, Kalume DE, de Mendonça-Lima L, Perales J, Fernandes O. Proteomic map of Trypanosoma cruzi CL Brener: the reference strain of the genome project. Arch Microbiol 2009;191(2):177-84.
107. Brisse S, Dujardin JC, Tibayrenc M. Identification of six Trypanosoma cruzi lineages by sequence-characterised amplified region markers. Mol Biochem Parasitol 2000;111:95-105.
108. Barnabe C, Neubauer K, Solari A, Tibayrenc M. Trypanosoma cruzi: presence of the two major phylogenetic lineages and of several lesser discrete typing units (DTUs) in Chile and Paraguay. Acta Trop 2001;78:127-137.
109. Buscaglia CA, Di Noia JM. Trypanosoma cruzi clonal diversity and the epidemiology of Chagas' disease. Microbes and Infection 2003;5:419-427.
110. Devera R, Fernandes O, Rodrigues-Coura J. Should Trypanosoma cruzi be called "cruzi" complex? A review of the parasite diversity and the potential of selecting population after in vitro culturing and mice infection. Mem Int Oswaldo Cruz 2003;98:1-12.
111. Huete-Perez JA, Flores-Obando RE, Ghedin E, Caffrey CR. Genomic and proteomic approaches for Chagas' disease: critical analysis of diagnostic methods. Expert Rev Mol Diagn 2005;5:521-530.
112. Westenberger SJ, Sturm NR, Campbell DA. Trypanosoma cruzi 5S rRNA arrays define five groups and indicate the geographic origins of an ancestor of the heterozygous hybrids. Int J Parasitol 2006;36:337-346.
113. Zingales B, Stolf BS, Souto RP, Fernandes O, Briones MR. Epidemiology, biochemistry and evolution of Trypanosoma cruzi lineages based on ribosomal RNA sequences. Mem Inst Oswaldo Cruz 1999;94(Suppl 1):159-164.
114. Bosseno MF, Barnabe C, Magallon-Gastelum E, Lozano-Kasten F, Ramsey J, Espinoza B, et al. Predominance of Trypanosoma cruzi lineage I in Mexico. J Clin Microbiol 2002;40:627-632.
115. Sanchez-Guillen MC, Bernabe C, Tibayrenc M, Zavala-Castro J, Totolhua JL, Méndez-Lopez J, et al. Trypanosoma cruzi strains isolated from human, vector, and animal reservoir in the same endemic region in Mexico and typed as T. cruzi I, discrete typing unit 1 exhibit considerable biological diversity. Mem Inst Oswaldo Cruz 2006;101(6):585-590.
116. Tibayrenc M. Genetic subdivisions within Trypanosoma cruzi (Discrete Typing Units) and their relevance for molecular epidemiology and experimental evolution. Kinetop Biol Dis 2003;2:12.
117. Higuchi MD, Ries MM, Aiello VD, Benvenuti LA, Gutierrez PS, Bellotti G, et al. Association of an increase in CD8+ T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis. Am J Trop Med Hyg 1997;56:485-489.
118. Higuchi ML. Chagas disease. Importance of the parasite in the pathogenesis of the cardiac chronic disease. Arq Bras Cardiol 1995;64:251-254.
119. Jones EM, Colley DG, Tostes S, Lopes ER, Vnencak-Jones C, McCurley TL. Amplification of Trypanosoma cruzi DNA sequences from inflammatory lesions in human chagasic cardiomyopathy. Am J Trop Med Hyg 1993;48:348-357.
120. Jones EM, Colley DG, Tostes SJ. Trypanosoma cruzi DNA sequences in human inflammatory cardiac lesions. Am J Trop Med Hyg 1993;48:348-355.
121. Correa-Oliveira R, Silva-Gomes JA, Moreira-Lemos E, Cardoso GM, Reis DD, Adad S, et al. The role of the immune response on the development of severe clinical forms of human Chagas disease. Mem Inst Oswaldo Cruz 1999;94(Suppl 1):253-255.
122. Campbell DA, Westenberger SJ, Sturm NR. The determinants of Chagas disease: connecting parasite and host genetics. Curr Mol Med 2004;4:549-562.
123. Neira I, Ferreira A, Yoshida N. Activation of distinct signal transduction pathways in Trypanosoma cruzi isolates with differential capacity to invade host cells. Int J Parasitol 2002;32:405-414.
124. Cruz-Robles D, Reyes PA, Monteon-Padilla VM, Ortiz-Muniz AR, Vargas-Alarcon G. MHC class I and class II genes in Mexican patients with Chagas disease. Hum Immunol 2004;65:60-65.
125. Andrade LO, Andrews NW. Lysosomal fusion is essential for the retention of Trypanosoma cruzi inside host cells. J Exp Med 2004;200:1135-1143.
126. Vercelli CA, Hidalgo AM, Hyon SH, Argibay PF. Trypanosoma cruzi trans-sialidase inhibits human lymphocyte proliferation by nonapoptotic mechanisms: implications in pathogenesis and transplant immunology. Transplant Proc 2005;37:4594-4597.
127. Manning-Cela R, Cortes A, Gonzalez-Rey E, Van Voorhis WC, Swindle J, Gonzalez A. LYT1 protein is required for efficient in vitro infection by Trypanosoma cruzi. Infect Immun 2001;69:3916-3923.
128. Yoshida N. Molecular basis of mammalian cell invasion by Trypanosoma cruzi. An Acad Bras Cienc 2006;78:87-111.
129. Garcia ES, Ratcliffe NA, Whitten MM, Gonzalez MS, Azambuja P. Exploring the role of insect host factors in the dynamics of Trypanosoma cruzi-Rhodnius prolixus interactions. J Insect Physiol 2007;53(1):11-21.
130. Kumar S, Tarleton RL. Antigen-specific Th1 but not Th2 cells provide protection from lethal Trypanosoma cruzi infection in mice. J Immunol 2001;166:4596-4603.
131. Hoft DF, EickhoffCS. Type 1 immunity provides optimal protection against both mucosal and systemic Trypanosoma cruzi challenges. Infect Immun 2002;70:6715-6725.
132. Schnapp AR, EickhoffCS, Sizemore D, Curtiss R III, Hoft DF. Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice. Infect Immun 2002;70:5065-5074.
133. Vasconcelos JR, Hiyane MI, Marinho CR, Claser C, Machado AM, Gazzinelli RT, et al. Protective immunity against Trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase. Hum Gene Ther 2004;15:878-886.
134. Martin DL, Weatherly DB, Laucella SA, Cabinian MA, Crim MT, Sullivan S, et al. CD8 T-cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog 2006;2:e77.
135. Vasconcelos JR, Boscardin SB, Hiyane MI, Kinoshita SS, Fujimura AE, Rodrigues MM. A DNA-priming protein-boosting regimen significantly improves type 1 immune response but not protective immunity to Trypanosoma cruzi infection in a highly susceptible mouse strain. Immunol Cell Biol 2003;81(2):121-129.
136. Musalem JS, Vaconcelos JRC, Squanella CC, Ananias RZ, Braga EG, Rodrigues MM. Adjuvant effect of the Propionibacterium acnes and its purified soluble polysaccharide on the immunization with plasmidal DNA containing a Trypanosoma cruzi gene. Microbial Immunol 2006;50:253-263.
137. Garg N, Tarleton RL. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infect Immun 2002;70:5547-5555.
138. Price HP, Panethymitaki C, Goulding D, Smith DF. Functional analysis of TbARL1, an N-myristoylated Golgi protein essential for viability in bloodstream trypanosomes. J Cell Sci 2005;118:831-841.
139. Nde PN, Simmons KJ, Kleshchenko YY, Pratap S, Lima MF, Villalta F. Silencing of the laminin gamma-1 gene blocks Trypanosoma cruzi infection. Infect Immun 2006;74:1643-1648.
140. Simmons KJ, Nde PN, Kleshchenko YY, Lima MF, Villalta F. Stable RNA interference of host thrombospondin-1 blocks Trypanosoma cruzi infection. FEBS Lett 2006;580:2365-2370.
141. Garcia ES, Guimaraes JA, Prado JL. Purification and characterization of a sulfhydryl-dependent protease from Rhodnius prolixus midgut. Arch Biochem Biophys 1978;188:315-322.
142. Marquardt WC. Hemimetabolic vectors and some cyclophoran flies and the agents they transmit. In: Beaty BJ y Marquardt WC (ed.). The biology of disease vectors. USA: University Press of Colorado, 1994.
143. Tyler KM, Engman DE. Flagellar elongarion induced by glucose limitation is preadaptive for Trypanosoma cruzi differentiation. Cell Motil Cytoskeleton 2000;46:269-278.
144. Billingsley PF, Downe AER. Ultrastructural localization of Cathepsin B in the midgut of Rhodnius prolixus Stal (Hemiptera:Reduviidae) during blood digestion. Int J Insect Morphol & Embryol 1988;17:295-302.
145. Lopez-Ordoñez T, Rodriguez MH, Hernández-Hernández FD. Characterization of a cDNA encoding a cathepsin L-like protein of Rhodnius prolixus. Insect Mol Biol 2001;10(5):505-511.
146. Ursic-Bedoya RJ, Lowenberger CA. Rhodnius prolixus: identification of immune-related genes up-regulated in response to pathogens and parasites using suppressive subtractive hybridization. Dev Comp Immunol 2007;31(2):109-120.
147. Garcia ES, Azambuja P. Development and interactions of Trypanosoma cruzi within the insect vector. Parasitol Today 1991;7(9):240-244.
148. Azambuja P, Garcia ES. Trypanosoma rangeli interactions within the vector Rhodnius prolixus: a mini review. Mem Inst Oswaldo Cruz 2005;100(5):567-572.
149. Alves CR, Albuquerque-Cunha JM, Mello CB, Garcia ES, Nogueira NF, Bourguingnon SC, et al. Trypanosoma cruzi: attachment to perimicrovillar membrane glycoproteins of Rhodnius prolixus. Exp Parasitol 2007;116(1):44-52.
150. Azambuja P, Garcia ES, Mello CB, Feder D. Immune responses in Rhodnius prolixus: influence of nutrition and ecdysone. J Insect Physiol 1997;43(6):513-519.
151. Lopez L, Morales G, Ursic R, WolffM, Lowenberger C. Isolation and characterization of a novel insect defensin from Rhodnius prolixus, a vector of Chagas disease. Insect Biochem Mol Biol 2003;33(4):439-447.
152. Garcia ES, Gonzalez MS, Azambuja P, Baralle FE, Frainderaich D, Torres HN, et al. Induction of Trypanosoma cruzi metacyclogenesis in the hematofagous insect vector by hemoglobin and peptides carrying alpha-D-globine sequences. Exp Parasitol 1995;81:255-261.
153. Garcia ES, Gonzalez MS, Azambuja P. Biological factors involving Trypanosoma cruzi life cycle in the invertebrate vector Rhodnius prolixus. Mem Inst Oswaldo Cruz 1999;94(Suppl 1):213-216.
154. Azambuja, P Feder D, Mello CB, Gomes SAO, Garcia ES. Immunity in Rhodnius prolixus: trypanosomatid-vector interactions. Mem Inst Oswaldo Cruz 1999;94(Suppl 1):219-222.
155. Kollien AH, Schaub GA. The development of Trypanosoma cruzi in triatominae. Parasitol Today 2000;16(9):381-387.
156. Kollien AH, Schaub GA. Trypanosoma cruzi in the rectum of the bug Triatoma infestans: effects of blood ingestion of the vector and artificial diuresis. Parasitol Res 1997;83(8):781-788.
157. Ibarra-Cerdeña CN, Sánchez Cordero V, Towsend-Peterson A, Ramsey JM. Ecology of North American Triatominae. Acta Trop 2009;110(2-3):178-186.